Janet Napolitano - Aug 30, 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Director
Signature: /s/ Howard Horn, Attorney-in-Fact
Stock symbol: VIR
Transactions as of: Aug 30, 2021
Transactions value $: -$13,647
Form type: 4
Date filed: 8/31/2021, 04:58 PM
Previous filing: Aug 4, 2021
Next filing: Nov 4, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Options Exercise	$59.8K	+1.44K	+42.53%	$41.64	4.81K	Aug 30, 2021	Direct
transaction	VIR	Common Stock	Sale	-$73.4K	-1.44K	-29.84%	$51.15^*	3.37K	Aug 30, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Stock Option (Right to Buy)	Options Exercise	$0	+1.44K	+4.76%	$0.00	31.6K	Aug 30, 2021	Common Stock	1.44K	$41.64	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2021.
F2	1/3 of the shares subject to the stock option vested and became exercisable on August 28, 2021, and the remaining shares vest in 24 equal monthly installments thereafter.